Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.

PubWeight™: 1.56‹?› | Rank: Top 4%

🔗 View Article (PMID 19560507)

Published in Prog Neuropsychopharmacol Biol Psychiatry on June 26, 2009

Authors

Eugene Lin1, Po See Chen, Hui Hua Chang, Po-Wu Gean, Hsin Chun Tsai, Yen Kuang Yang, Ru-Band Lu

Author Affiliations

1: Vita Genomics, Inc, Wugu Shiang, Taipei, Taiwan.

Articles citing this

From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment. Can J Psychiatry (2014) 0.93

Association of the C825T polymorphism in the GNB3 gene with obesity and metabolic phenotypes in a Taiwanese population. Genes Nutr (2012) 0.90

Pharmacogenetics of antidepressants. Front Pharmacol (2011) 0.82

The serotonin transporter gene is a substrate for age and stress dependent epigenetic regulation in rhesus macaque brain: potential roles in genetic selection and gene × environment interactions. Dev Psychopathol (2012) 0.82

A roadmap to multifactor dimensionality reduction methods. Brief Bioinform (2015) 0.81

The relationship between single nucleotide polymorphisms in 5-HT2A signal transduction-related genes and the response efficacy to selective serotonin reuptake inhibitor treatments in Chinese patients with major depressive disorder. Genet Test Mol Biomarkers (2012) 0.77

Assessment of genetic and nongenetic interactions for the prediction of depressive symptomatology: an analysis of the Wisconsin Longitudinal Study using machine learning algorithms. Am J Public Health (2013) 0.76

TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients. Psychopharmacology (Berl) (2010) 0.75

No effect of serotoninergic gene variants on response to interpersonal counseling and antidepressants in major depression. Psychiatry Investig (2013) 0.75

Utilizing yeast chemogenomic profiles for the prediction of pharmacogenomic associations in humans. Sci Rep (2016) 0.75

Pilot study of an association between a common variant in the non-muscle myosin heavy chain 9 (MYH9) gene and type 2 diabetic nephropathy in a Taiwanese population. Appl Clin Genet (2010) 0.75

Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.75

Articles by these authors

A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. Am J Hum Genet (2002) 2.60

Developing a SNP panel for forensic identification of individuals. Forensic Sci Int (2005) 2.55

Acetylation of nuclear factor-kappaB in rat amygdala improves long-term but not short-term retention of fear memory. Mol Pharmacol (2004) 1.89

The similarities and diversities of signal pathways leading to consolidation of conditioning and consolidation of extinction of fear memory. J Neurosci (2003) 1.84

Identification of calcineurin as a key signal in the extinction of fear memory. J Neurosci (2003) 1.64

The risk factors of Internet addiction--a survey of university freshmen. Psychiatry Res (2009) 1.52

The evolution and population genetics of the ALDH2 locus: random genetic drift, selection, and low levels of recombination. Ann Hum Genet (2004) 1.49

Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol (2008) 1.38

Extinction training in conjunction with a partial agonist of the glycine site on the NMDA receptor erases memory trace. J Neurosci (2006) 1.36

Regulation of amygdala-dependent learning by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol-3-kinase. Neuropsychopharmacology (2006) 1.35

Involvement of a calcineurin cascade in amygdala depotentiation and quenching of fear memory. Mol Pharmacol (2003) 1.33

The distribution and most recent common ancestor of the 17q21 inversion in humans. Am J Hum Genet (2010) 1.31

A study on the sleep quality of incoming university students. Psychiatry Res (2012) 1.27

Synaptic expression of glutamate receptor after encoding of fear memory in the rat amygdala. Mol Pharmacol (2005) 1.21

Transcriptional regulation of brain-derived neurotrophic factor in the amygdala during consolidation of fear memory. Mol Pharmacol (2007) 1.16

The role of prefrontal cortex CB1 receptors in the modulation of fear memory. Cereb Cortex (2008) 1.15

The role of the amygdala in the extinction of conditioned fear. Biol Psychiatry (2006) 1.10

A requirement of nuclear factor-kappaB activation in fear-potentiated startle. J Biol Chem (2002) 1.09

Study of hepatotoxicity of naltrexone in the treatment of alcoholism. Alcohol (2006) 1.09

A global view of the OCA2-HERC2 region and pigmentation. Hum Genet (2011) 1.08

Name change for schizophrenia. Schizophr Bull (2014) 1.08

Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation. Neuropsychopharmacology (2009) 1.07

Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcohol Clin Exp Res (2004) 1.07

Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers--a SPECT study. Neuroimage (2007) 1.04

Effects of intra-amygdala infusion of CB1 receptor agonists on the reconsolidation of fear-potentiated startle. Learn Mem (2006) 1.04

Late expression of brain-derived neurotrophic factor in the amygdala is required for persistence of fear memory. Neurobiol Learn Mem (2009) 1.01

Activation of group II metabotropic glutamate receptors induces depotentiation in amygdala slices and reduces fear-potentiated startle in rats. Learn Mem (2005) 1.01

Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation. Hum Genet (2002) 1.01

Block of gamma-aminobutyric acid-A receptor insertion in the amygdala impairs extinction of conditioned fear. Biol Psychiatry (2009) 1.01

Hypomania: a transcultural perspective. World Psychiatry (2010) 0.99

Validation of the Chinese version of the hypomania checklist (HCL-32) as an instrument for detecting hypo(mania) in patients with mood disorders. J Affect Disord (2007) 0.99

Pharmacokinetic and pharmacodynamic basis for overcoming acetaldehyde-induced adverse reaction in Asian alcoholics, heterozygous for the variant ALDH2*2 gene allele. Pharmacogenet Genomics (2009) 0.98

Minocycline inhibits the growth of glioma by inducing autophagy. Autophagy (2011) 0.97

Mediation of amphetamine-induced long-term depression of synaptic transmission by CB1 cannabinoid receptors in the rat amygdala. J Neurosci (2003) 0.96

Selective inhibition of early--but not late--expressed HIF-1α is neuroprotective in rats after focal ischemic brain damage. Brain Pathol (2010) 0.96

Greater availability of dopamine transporters in patients with major depression--a dual-isotope SPECT study. Psychiatry Res (2008) 0.95

Decreased dopamine transporter availability in male smokers -- a dual isotope SPECT study. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.95

Glutamate preconditioning prevents neuronal death induced by combined oxygen-glucose deprivation in cultured cortical neurons. Eur J Pharmacol (2008) 0.94

Anti-NMDA receptor encephalitis with the initial presentation of psychotic mania. J Clin Neurosci (2012) 0.94

The amygdala excitatory/inhibitory balance in a valproate-induced rat autism model. PLoS One (2013) 0.93

Dopamine transporter gene may be associated with bipolar disorder and its personality traits. Eur Arch Psychiatry Clin Neurosci (2014) 0.93

Augmentation of fear extinction by D-cycloserine is blocked by proteasome inhibitors. Neuropsychopharmacology (2008) 0.92

Calcitonin induces podosome disassembly and detachment of osteoclasts by modulating Pyk2 and Src activities. Bone (2007) 0.92

Two case studies of hypothermia induced by an increased dosage of zotepine in a combination therapy. Psychiatry Clin Neurosci (2003) 0.92

The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia. Int J Nurs Stud (2004) 0.91

Acetaldehyde involvement in positive and negative alcohol expectancies in han Chinese persons with alcoholism. Arch Gen Psychiatry (2006) 0.91

Alterations of excitatory transmission in the lateral amygdala during expression and extinction of fear memory. Int J Neuropsychopharmacol (2009) 0.91

Histone acetylation is essential for ANG-II-induced IGF-IIR gene expression in H9c2 cardiomyoblast cells and pathologically hypertensive rat heart. J Cell Physiol (2012) 0.91

High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan. J Affect Disord (2009) 0.91

Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence. J Psychiatry Neurosci (2007) 0.90

The role of valproate in metabolic disturbances in bipolar disorder patients. J Affect Disord (2010) 0.90

Pharmacogenomics with antidepressants in the STAR*D study. Pharmacogenomics (2008) 0.90

Hypoxia-inducible factor-1alpha protects cultured cortical neurons from lipopolysaccharide-induced cell death via regulation of NR1 expression. J Neurosci (2008) 0.89

MAOA interacts with the ALDH2 gene in anxiety-depression alcohol dependence. Alcohol Clin Exp Res (2010) 0.89

Amelioration of social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit by N-acetylcysteine in a transgenic mouse model. Neurobiol Dis (2011) 0.89

β2-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway. J Immunol (2011) 0.89

Treatment response and cognitive impairment in major depression: association with C-reactive protein. Brain Behav Immun (2011) 0.88

Chronic cannabinoid administration in vivo compromises extinction of fear memory. Learn Mem (2008) 0.88

The interaction between BDNF and DRD2 in bipolar II disorder but not in bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet (2012) 0.88

The functionality and economic costs of outpatients with schizophrenia in Taiwan. Psychiatry Res (2008) 0.88

Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: A SPECT study. Eur Neuropsychopharmacol (2006) 0.87

Microglial regulation of immunological and neuroprotective functions of astroglia. Glia (2014) 0.87

Smoking and psychosis in patients with bipolar I disorder. Compr Psychiatry (2002) 0.87

Neuropsychological functions in patients with bipolar I and bipolar II disorder. Bipolar Disord (2009) 0.87

Low-dose memantine attenuated morphine addictive behavior through its anti-inflammation and neurotrophic effects in rats. J Neuroimmune Pharmacol (2011) 0.87

Association of promoter variants of human dopamine transporter gene with schizophrenia in Han Chinese. Schizophr Res (2010) 0.86

Effects of C825T polymorphism of the GNB3 gene on availability of dopamine transporter in healthy volunteers--a SPECT study. Neuroimage (2011) 0.86

The DRD2/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder. J Affect Disord (2012) 0.85

GABAA receptor endocytosis in the basolateral amygdala is critical to the reinstatement of fear memory measured by fear-potentiated startle. J Neurosci (2011) 0.85

Possible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in Taiwan. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.85

Association between cognitive performance and striatal dopamine binding is higher in timing and motor tasks in patients with schizophrenia. Psychiatry Res (2004) 0.85

Long-acting injectable antipsychotics for first-episode schizophrenia: the pros and cons. Schizophr Res Treatment (2012) 0.85

Inhibition of glioma growth by minocycline is mediated through endoplasmic reticulum stress-induced apoptosis and autophagic cell death. Neuro Oncol (2013) 0.85

Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study. Am J Psychiatry (2004) 0.85

The association between DRD2/ANKK1, 5-HTTLPR gene, and specific personality trait on antisocial alcoholism among Han Chinese in Taiwan. Am J Med Genet B Neuropsychiatr Genet (2008) 0.84

AMPA receptor endocytosis in the amygdala is involved in the disrupted reconsolidation of Methamphetamine-associated contextual memory. Neurobiol Learn Mem (2013) 0.84

Inhibition of spontaneous recovery of fear by mGluR5 after prolonged extinction training. PLoS One (2013) 0.84

Correlation between different memory systems and striatal dopamine D2/D3 receptor density: a single photon emission computed tomography study. Psychol Med (2005) 0.84

Neuroprotective effects of ugonin K on hydrogen peroxide-induced cell death in human neuroblastoma SH-SY5Y cells. Neurochem Res (2008) 0.83

Availability of dopamine and serotonin transporters in opioid-dependent users--a two-isotope SPECT study. Psychopharmacology (Berl) (2011) 0.83

Norms of performance of sustained attention among a community sample: Continuous Performance Test study. Psychiatry Clin Neurosci (2005) 0.83

Correlation between striatal dopamine D2 receptor density and neuroticism in community volunteers. Psychiatry Res (2005) 0.83

Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder. J Psychiatr Res (2013) 0.83

The ALDH2 and 5-HT2A genes interacted in bipolar-I but not bipolar-II disorder. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.83

Association of novelty seeking scores and striatal dopamine D₂/D₃ receptor availability of healthy volunteers: single photon emission computed tomography with ¹²³i-iodobenzamide. J Formos Med Assoc (2010) 0.83